0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Rare Hemophilia Factors Market to Reach USD 247 Million by 2031 | CAGR 3.1%According to a newly published market research report by 24LifeSciences, global rare hemophilia factors market was valued at USD 200 million in 2024 and is projected to reach USD 247 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025-2031. Rare hemophilia factors represent specialized blood-clotting proteins essential for treating...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
US Blood Coagulation Factor Market Trends, Competitive Analysis and Future OpportunitiesThe blood coagulation factor market is experiencing consistent growth due to the increasing prevalence of bleeding disorders, advancements in recombinant therapies, and rising awareness regarding early diagnosis and treatment. Blood coagulation factors are essential therapeutic products used to manage inherited and acquired coagulation disorders, particularly hemophilia and other rare bleeding...0 Комментарии 0 Поделились 101 Просмотры 0 предпросмотр